Treating CME Without Reactivating Retinitis - Takeaways - MDSpire

Treating CME Without Reactivating Retinitis

Data from a retrospective Emory Eye Center series suggest most eyes with CME following infectious retinitis achieved resolution without disease reactivation, although prolonged treatment and close monitoring were often required.

  • By

  • Sruthi Arepalli, MD

  • July 15, 2026

  • 3 min

Share

  • 1

    A retrospective study at Emory Eye Center found most eyes with CME after infectious retinitis resolved without disease reactivation.

  • 2

    Topical steroid drops were the primary treatment for CME, often requiring prolonged use and multiple cycles for resolution.

  • 3

    Local and systemic steroids were used less frequently but showed higher resolution rates, raising concerns about disease reactivation.

  • 4

    Seventy-five percent of eyes achieved resolution, with eight additional eyes showing marked improvement by the follow-up period.

  • 5

    No cases of disease reactivation were reported, although some patients experienced increased intraocular pressure.

Original Source(s)

Treating CME Without Reactivating Retinitis

  • by Sruthi Arepalli, MD

  • July 15, 2026

Related Content

Merck Highlights Early Tiespectus Data

At the ASRS meeting in Montreal, Baruch D. Kuppermann, MD, PhD, presented BRVO findings from the phase 1/2a RIOJA program evaluating the investigational VEGF/Tie2 bispecific.

Can Oral Gildeuretinol Slow Advanced Macular Degeneration?

Although the trial missed its primary endpoint, exploratory analyses suggested slower lesion growth and better functional outcomes with gildeuretinol.

Elevated GDF15 in ocular fluids of patients with proliferative diabetic retinopathy